Coverage request for positron emission tomography (PET) used in the evaluation of Alzheimer's disease and related dementias
Guidance for request is being submitted by a broad range of professionals involved in clinical care and research devoted to the welfare of patients with Alzheimer's disease and related dementias. regarding the request for new and more restricted coverage for the use of Positron Emission Tomography (PET) for assisting physicians in the diagnosis of mild to moderate Alzheimer's Disease, than submitted to CMS on October 12, 2001.
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: August 14, 2003
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.